Diabetes

By Laura Lovett 01:55 pm June 3, 2020
This morning Bigfoot Biomedical, a diabetes startup focused on automating insulin delivery through a connected insulin pen, picked up an extra $10 million Series C funding, closing the round at $55 million. Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.  When the first $45 million...
By Dave Muoio 02:55 pm April 27, 2020
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health. Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...

Credit: Sehat Kahani

By Leontina Postelnicu 09:43 am March 13, 2020
A nation of over 200 million citizens, Pakistan is a major player in South Asia, with a large population to care for. Like many countries around the world, it is struggling to address the shortage of doctors and prevalence of chronic diseases while ensuring access to affordable medicine. But where there are challenges, there is also room for innovation. Today, we are seeing entrepreneurs and...
By Dave Muoio 04:06 pm March 12, 2020
Together in perfect harmony. Dexcom and Welldoc have kicked off a new collaboration that will provide Dexcom G6 continuous glucose monitor users with data-analysis insights from Welldoc's digital diabetes management product, BlueStar. These insights include information on how lifestyle factors such as activity, nutrition, sleep and medication adherence are affecting a user's glucose levels. “Now...
By Dave Muoio 02:26 pm March 3, 2020
It was another strong quarter for the ever-growing Livongo Health, which yesterday reported to investors a 137% rise in year-over-year Q4 revenue from $21.2 million to $50.2 million. Full-year revenues followed a similar path, growing 149% from $68.4 million in 2018 to $169.9 million in 2019. “Livongo finished the year with excellent momentum, exceeding all of our guidance metrics, achieving...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Laura Lovett 02:13 pm January 13, 2020
Dexcom’s G6 Continuous Glucose Monitoring system will soon be integrated with Livongo’s platform, thanks to a new partnership between the two diabetes-focused companies.  G6 users who are also Livongo members will be able to sync their device to the Livongo platform, which will be able to give users insights and health nudges about their behavior based on the CGM reading. The system will also be...
By Jonah Comstock 11:33 am December 17, 2019
Dublin-based medical technology company Medtronic has acquired digital health startup Klue, a two-year-old startup which uses gesture sensing and other behavioral health metrics to determine when someone is eating. Nothing was disclosed about the terms of the deal, except that Medtronic considers it to be immaterial to 2020 earnings per share. "Bringing Klue and their unique meal detection...
By Dave Muoio 03:23 pm December 16, 2019
Somerville, Massachusetts-based Podimetrics has bumped its $13.4 million Series B funding round up to $16.55 thanks to a new investment from Polaris Partners. The company, which makes a connected platform for diabetic foot ulcer detection, also announced the addition of five new names to advisory board: Dr. Kenneth Kizer, former Veterans Affairs undersecretary for health; Dr. Ronald Geraty, a...
By Dave Muoio 03:48 pm December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses. Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...